United States · FDA National Drug Code directory
DROXIA
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 80725-840_3feae4e9-790a-41c7-94df-6baf3ec503ff
- Product NDC
- 80725-840
- Form
- CAPSULE
- Composition / generic term
- Hydroxyurea
- Labeler
- Waylis Therapeutics LLC
- Marketing category
- NDA
- Marketing start / end (source format)
- 20250911
- Source listing expiry
- 20261231
Source-listed ingredients
- HYDROXYUREA — 400 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 60 CAPSULE in 1 BOTTLE (80725-840-60) · 80725-840-60
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →